Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

Intercont (Cayman) Ltd (NCT)

6-K Dilutive issuance confidence 95% filed 2026-07-09 EX-99.1

This press release announces the pricing of a public offering of 8,000,000 units at $0.79 per unit, generating approximately $6.32 million in gross proceeds. Each unit comprises one Class A ordinary share and one warrant, representing a dilutive equity issuance. The offering is registered on Form F-1 and is material to investors as it significantly increases share count and dilutes existing shareholders.

View raw filing on EDGAR →

REGENTIS BIOMATERIALS LTD. (RGNT)

6-K Shareholder vote confidence 95% filed 2026-07-09

The 6-K discloses the results of an Adjourned Annual General Meeting of Shareholders held on July 9, 2026, in which all fourteen proposals were approved by the required majority. This is a direct disclosure of shareholder vote results, matching the definition of Item 5.07 (shareholder_vote_results). The approval of multiple proposals at an annual meeting, including governance and potentially compensation matters, is material to investors' understanding of the company's governance and strategic direction.

View raw filing on EDGAR →

Happy City Holdings Ltd (HCHL)

6-K Delisting risk confidence 95% filed 2026-07-09

The 6-K discloses that on June 29, 2026, Nasdaq halted trading in the Company's Class A ordinary shares pending satisfaction of Nasdaq's request for additional information, with trading to remain halted until the Company fully complies. This constitutes a material delisting risk under Item 3.01 equivalent, as the trading halt is a precursor to potential delisting and directly threatens the Company's continued listing status on Nasdaq.

View raw filing on EDGAR →

AIR INDUSTRIES GROUP (AIRI)

8-K M&A activity confidence 97% filed 2026-07-09 Item 1.01

Air Industries Group entered into an Amended and Restated Agreement and Plan of Merger with Tenax Aerospace Acquisition, LLC on July 2, 2026, superseding the original merger agreement from February 16, 2026. The transaction involves issuance of 126.9 million shares of AIR common stock (25.38 million post-reverse split) to Tenax members, resulting in Tenax members owning approximately 96% of the combined company post-closing, constituting a material change of control requiring stockholder approval and SEC registration on Form S-4.

View raw filing on EDGAR →

Hongli Group Inc. (HLP)

6-K Delisting risk confidence 98% filed 2026-07-09 EX-99.1

Hongli Group received a Nasdaq deficiency notice on July 2, 2026, for failure to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The Company has 180 calendar days (until December 29, 2026) to regain compliance or face potential delisting. The press release explicitly states that if the Company does not cure the deficiency and does not meet eligibility criteria for an extension, "Nasdaq will provide notice that its securities will be subject to delisting." This is a material disclosure of delisting risk under Item 3.01 equivalent.

View raw filing on EDGAR →

Fermi Inc. (FRMI)

8-K Debt Issuance confidence 92% filed 2026-07-09 Item 7.01

Fermi Inc. commenced an offering of $350 million aggregate principal amount of convertible senior notes due 2031, with an additional $52.5 million option for initial purchasers. Net proceeds are intended for capped call transactions and general corporate purposes.

View raw filing on EDGAR →

Plum Acquisition Corp, IV (PLMKU)

8-K Governance Other confidence 75% filed 2026-07-09 Item 8.01

This disclosure announces an estimated redemption price ($10.6973 per share) in connection with a shareholder meeting scheduled for July 10, 2026, where shareholders will vote on an Extension Amendment Proposal to extend the business combination deadline from July 16, 2026 to January 16, 2027, with optional monthly extensions. While the filing involves shareholder voting and governance matters, it does not fit the specific `shareholder_vote_results` category (which applies to results *after* a vote), nor does it fit other named governance types. The announcement of the redemption price and extension terms is a material governance event affecting shareholder rights and the company's timeline, making `governance_other` the most appropriate classification.

View raw filing on EDGAR →

Constellation Acquisition Corp I (CSTUF)

8-K M&A activity confidence 92% filed 2026-07-09 Item 7.01

The filing discloses a virtual investor conversation regarding the proposed business combination between Constellation Acquisition Corp I (CSTA), HiTech Minerals Inc., and US Elemental Inc. (PubCo), with anticipated Nasdaq listing. Although Item 7.01 is technically a Regulation FD disclosure of the event invitation itself, the substance centers on a material M&A transaction—the business combination and resulting public listing—which is the core event being communicated to investors. The filing explicitly references the "proposed business combination" multiple times and discusses the anticipated listing of PubCo on Nasdaq, making this a material acquisition/change-of-control event.

View raw filing on EDGAR →

Eureka Acquisition Corp (EURKU)

8-K Debt Issuance confidence 90% filed 2026-07-09 Item 2.03

Eureka Acquisition Corp issued an unsecured promissory note (Extension Note) in the principal amount of $8,253.03 to Marine Thinking Inc. on July 7, 2026, creating a direct financial obligation with standard default provisions and a conversion feature into private units.

View raw filing on EDGAR →

Eureka Acquisition Corp (EURKU)

8-K M&A activity confidence 85% filed 2026-07-09 Item 3.02

Eureka Acquisition Corp disclosed a proposed business combination with Marine Thinking, including registration rights and transfer restrictions for units issuable upon conversion of the Extension Note, with a Form S-4 registration statement filed in connection with the transaction.

View raw filing on EDGAR →

BSTR Newco, LLC

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 1.01

BSTR Newco entered into a loan agreement on March 15, 2026 for $2.5 million, subsequently amended on June 2, 2026 and July 8, 2026 to increase the principal sum to $4.6 million total. The loan carries an interest rate of SOFR + 3.90% and is material to the registrant's financing for operating costs and transaction expenses related to a pending business combination.

View raw filing on EDGAR →

Biodexa Pharmaceuticals Plc (BDRX)

6-K Governance Other confidence 92% filed 2026-07-09 EX-99.1

Biodexa Pharmaceuticals PLC is holding an Extraordinary General Meeting on July 29, 2026, to approve four material resolutions: (1) a 10,000-to-1 share consolidation with creation of deferred shares; (2) authorization to allot up to £25,000,000 in equity securities; (3) disapplication of pre-emption rights for cash issuances; and (4) adoption of new articles of association. These structural and constitutional changes materially affect the company's capital structure and future financing flexibility.

View raw filing on EDGAR →

Orla Mining Ltd. (ORLA)

6-K Earnings release confidence 92% filed 2026-07-09 EX-99.1

This is a news release dated July 9, 2026 disclosing Orla Mining's second quarter 2026 operating results, including gold production figures (88,265 ounces in Q2, 169,471 ounces YTD), operational metrics for Musselwhite and Camino Rojo mines, liquidity position ($451.0 million cash, $318.7 million net cash), and reaffirmation of 2026 production guidance (340,000–360,000 ounces). The release explicitly states "Orla expects to release its second quarter 2026 operating and financial results on Tuesday, August 4, 2026," confirming this is an operational and financial results announcement. Material to investors assessing operational performance and cash generation.

View raw filing on EDGAR →

Vale S.A. (VALE)

6-K Exec departure confidence 95% filed 2026-07-09

Daniel André Stieler resigned as Chairman of the Board of Directors and board member of Vale S.A. effective July 6, 2026. The 6-K furnishes Vale's official response to a Brazilian securities regulator (CVM) inquiry regarding media reports of his resignation and associated compensation arrangements. The departure of a board chairman is a material governance event affecting investor assessment of the company's leadership and control structure.

View raw filing on EDGAR →

Sigma Lithium Corp (SGML)

6-K Earnings release confidence 92% filed 2026-07-09 EX-99.1

This is a press release announcing Sigma Lithium's second-quarter 2026 operational and production results. The company reports producing 35,000 tonnes of lithium oxide concentrate in 2Q26, exceeding guidance of 33,000 tonnes by 6%, and provides forward-looking production volumes and cash-flow forecasts for Phases 1, 2, and 3. The release explicitly states "Sigma Lithium expects to release its full second quarter 2026 financial and operating results on August 14, 2026," confirming this is an interim operational disclosure ahead of full financial results. The disclosure of production metrics, operational efficiency improvements, and forward guidance materially affects investor assessment of the company's execution and growth trajectory.

View raw filing on EDGAR →

PETROBRAS - PETROLEO BRASILEIRO SA (PBR-A)

6-K M&A activity confidence 95% filed 2026-07-09

Petrobras announces completion of acquisition of exploration block in São Tomé and Príncipe, Africa, with Petrobras taking 75% operatorship interest. This is a material acquisition of an oil and gas exploration asset aligned with the company's reserve-replenishment strategy, representing entry into a new geographic frontier and portfolio diversification.

View raw filing on EDGAR →

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

8-K Exec departure confidence 95% filed 2026-07-09 Item 5.02

Christopher M. Smith, a board member of Pacific Biosciences, resigned from the Board effective immediately on July 8, 2026. The disclosure centers on the departure itself, with explicit confirmation that no disagreement with the Company prompted the resignation. This is a straightforward director departure under Item 5.02, material to investors as board composition affects governance and oversight.

View raw filing on EDGAR →

JLL Income Property Trust, Inc.

8-K Dividend Distribution confidence 95% filed 2026-07-09 Item 7.01

JLL Income Property Trust's Board declared a monthly dividend of $0.0525 per share for July 2026, payable on or around July 24, 2026. The press release explicitly announces this distribution declaration and provides details on the annualized distribution rate (approximately 5.6% on NAV of $11.27). This is a routine but material dividend declaration typical of REIT disclosures, affecting investor returns and capital allocation decisions.

View raw filing on EDGAR →

Federal Home Loan Bank of San Francisco

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 2.03

The filing discloses the issuance of consolidated obligation bonds by the Federal Home Loan Bank of San Francisco under Item 2.03. Schedule A reports a $15 million bond with a trade date of 7/07/2026, settlement date of 7/16/2026, and maturity date of 7/16/2029, with a 4.300% coupon. This represents the creation of a direct financial obligation through debt issuance, which is the core purpose of Item 2.03 disclosures.

View raw filing on EDGAR →

Federal Home Loan Bank of Des Moines

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 2.03

The filing discloses the creation of multiple direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines. Schedule A lists specific debt securities issued on trade dates in July 2026, with principal amounts totaling approximately $4.6 billion across variable-rate floaters and fixed-rate callable bonds. This is a classic debt issuance disclosure under Item 2.03, material to investors assessing the Bank's capital structure and funding activities.

View raw filing on EDGAR →

Federal Home Loan Bank of Topeka

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 2.03

The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Topeka. Schedule A details eight separate debt issuances with trade dates of 07/06/2026 and 07/07/2026, totaling approximately $2.1 billion in principal across fixed-rate bonds and variable-rate floaters with maturities ranging from November 2026 to July 2046. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations of the registrant.

View raw filing on EDGAR →

Federal Home Loan Bank of Cincinnati

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 2.03

The filing discloses the issuance of a Consolidated Bond with a principal amount of $15,000,000, trade date 7/6/2026, maturing 10/9/2029, at a 4.400% coupon rate. This represents a direct financial obligation created by the FHLB through the sale of debt securities in the capital markets, which is the core purpose of Item 2.03 disclosures. The filing explicitly states that "Consolidated Obligations issuance is material to the FHLB," and debt issuance by a Federal Home Loan Bank is material to investors assessing the registrant's capital structure and funding activities.

View raw filing on EDGAR →

Federal Home Loan Bank of Pittsburgh

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 2.03

The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Pittsburgh. Schedule A lists multiple debt securities issued on trade dates of 7/6/2026 and 7/7/2026, with principal amounts totaling approximately $3.63 billion across various maturities and rate structures. This is a classic debt issuance under Item 2.03, and the registrant explicitly notes that "consolidated obligations issuance is material to the FHLBank."

View raw filing on EDGAR →

Federal Home Loan Bank of Chicago

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 2.03

The filing discloses the issuance of consolidated obligation bonds totaling $165 million across three trade dates (7/6/2026 and 7/7/2026) with maturities ranging from 2030 to 2051. Schedule A explicitly lists the principal amounts, CUSIPs, settlement dates, coupon rates, and call provisions for these newly issued debt securities. The Bank notes that "consolidated obligations issuance is material to the Bank," and the Item 2.03 classification confirms this is a creation of direct financial obligations through debt issuance in the capital markets.

View raw filing on EDGAR →

Federal Home Loan Bank of Boston

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 2.03

The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Boston. Schedule A details two specific debt issuances on trade date 7/7/2026: a $15 million bond maturing 7/20/2028 with a 4.350% coupon and a $50 million discount note maturing 2/5/2027 with a 3.920% coupon. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations of the registrant.

View raw filing on EDGAR →

Federal Home Loan Bank of Atlanta

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 2.03

The filing discloses the creation of a direct financial obligation through the issuance of consolidated obligation bonds by the Federal Home Loan Bank of Atlanta. Schedule A reports a $10 million bond with a trade date of 7/7/2026, settlement date of 7/10/2026, and maturity date of 7/10/2031, with a 4.35% coupon. This is a classic debt issuance under Item 2.03, creating a new direct financial obligation for the Bank.

View raw filing on EDGAR →

Federal Home Loan Bank of Indianapolis

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 2.03

The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds with aggregate par value of $50 million across three tranches (maturing 2028, 2029, and 2031 with coupons ranging from 4.250% to 4.650%). This is a direct creation of financial obligations under Item 2.03, constituting a material debt issuance by the registrant.

View raw filing on EDGAR →

Federal Home Loan Bank of Dallas

8-K Debt Issuance confidence 95% filed 2026-07-09 Item 2.03

The filing discloses the creation of a direct financial obligation through the issuance of a consolidated obligation bond by the Federal Home Loan Bank of Dallas. Schedule A reports a $20 million bond committed to be issued on 7/6/2026 with a 5.9% coupon and 25-year maturity (7/20/2051). This is a classic debt issuance under Item 2.03, creating a new direct financial obligation for the registrant.

View raw filing on EDGAR →

Brookdale Senior Living Inc. (BKD)

8-K Earnings release confidence 92% filed 2026-07-09 Item 2.02

Brookdale issued a press release on July 9, 2026 announcing occupancy metrics for June 2026 and quarterly results for the period ended June 30, 2026, including consolidated and same-community occupancy data with year-over-year and sequential comparisons.

View raw filing on EDGAR →

MESOBLAST LTD (MEOBF)

6-K Earnings release confidence 95% filed 2026-07-09 EX-99.1

This exhibit is a press release announcing Ryoncil® net revenue of US$36 million for Q4 FY2026 and US$115 million for the full fiscal year ended June 30, 2026. The disclosure presents quarterly and annual financial results for the company's lead commercial product, with management commentary on revenue growth exceeding initial projections and anticipated continued growth. This is a classic earnings release announcing periodic financial results.

View raw filing on EDGAR →

Main Street Capital CORP (MAIN)

8-K Earnings release confidence 92% filed 2026-07-09 Item 2.02

Main Street Capital issued a press release on July 9, 2026 disclosing second quarter 2026 portfolio activity, including originations of $319.0 million in new or increased commitments and $238.9 million in funded investments across its private loan portfolio. This is a quarterly operational and financial results disclosure typical of earnings releases filed under Item 2.02, providing investors with material information about the company's investment activity and portfolio composition as of June 30, 2026.

View raw filing on EDGAR →

ALTERITY THERAPEUTICS LTD (PRNAF)

6-K Financial Other confidence 85% filed 2026-07-09 EX-99.1

Alterity announced receipt of an A$3.98 million R&D tax refund from the Australian Government for the 2025 financial year. This is a material cash inflow that affects the company's liquidity and funding position for its clinical programs, but does not fit neatly into standard event categories (not debt issuance, dividend, or capital raise). It is clearly a financial event—a government tax incentive payment—that would affect a reasonable investor's assessment of the company's cash position and runway.

View raw filing on EDGAR →

ConnectOne Bancorp, Inc. (CNOBP)

8-K Earnings release confidence 95% filed 2026-07-09 Item 8.01

The press release announces ConnectOne Bancorp's plan to release second quarter 2026 financial results on July 23, 2026, and to host a conference call with Chairman and CEO Frank Sorrentino III and CFO William S. Burns to review the Company's financial performance and operating results. This is a standard earnings release announcement disclosing quarterly financial results, which is material to investors assessing the registrant's financial condition and performance.

View raw filing on EDGAR →

Byrna Technologies Inc. (BYRN)

8-K Earnings release confidence 95% filed 2026-07-09 Item 2.02

This is a clear earnings release disclosing Byrna Technologies' financial results for the fiscal second quarter ended May 31, 2026. The press release, attached as Exhibit 99.1, reports net revenue of $16.4 million (down 43% year-over-year), a net loss of $(10.1) million (versus net income of $2.4 million in Q2 2025), and includes material non-cash charges including a $5.9 million inventory write-down and $3.5 million equipment impairment. The disclosure is material as it reflects significant operational challenges and a substantial deterioration in financial performance compared to the prior year.

View raw filing on EDGAR →

Capstone Holding Corp. (CAPS)

8-K Delisting risk confidence 95% filed 2026-07-09 Item 8.01

The filing discloses that Capstone received notice from Nasdaq on July 8, 2026, that it has failed to maintain the minimum $1.00 per share bid price requirement and has been granted an additional 180-calendar-day cure period until January 4, 2027, after which Nasdaq will delist the company's common stock if compliance is not regained. This is a direct delisting risk notification under Nasdaq Listing Rule 5550(a)(2), materially affecting the registrant's continued listing status.

View raw filing on EDGAR →

HYDROFARM HOLDINGS GROUP, INC. (HYFM)

8-K Delisting risk confidence 98% filed 2026-07-09 Item 3.01

Hydrofarm received a determination letter from Nasdaq on July 2, 2026, stating it failed to meet the terms of an extension to regain compliance with the $2.5 million minimum stockholders' equity requirement (Listing Rule 5550(b)(1)). The company also received notice on July 6, 2026, of non-compliance with the minimum bid price requirement (Listing Rule 5550(a)(2)). While the company requested a hearing that stayed delisting action pending the Panel's decision, the disclosure explicitly addresses failure to satisfy continued listing rules and the material risk of delisting, which is the core substance of Item 3.01.

View raw filing on EDGAR →

IMMUCELL CORP /DE/ (ICCC)

8-K Earnings release confidence 95% filed 2026-07-09 Item 2.02

ImmuCell issued a press release on July 9, 2026 announcing preliminary, unaudited Q2 2026 sales results showing an 11.5% increase in product sales compared to Q2 2025 ($7.2M vs. $6.4M), with strong domestic growth of 27.7%. The full press release is attached as Exhibit 99.1, which is the standard format for earnings disclosures under Item 2.02. This is a material earnings announcement that would affect a reasonable investor's assessment of the company's financial performance.

View raw filing on EDGAR →

CervoMed Inc. (CRVO)

8-K Operational Other confidence 75% filed 2026-07-09 Item 8.01

CervoMed announced completion of enrollment in a Phase 2a clinical trial of neflamapimod for nonfluent variant primary progressive aphasia (nfvPPA), with interim biomarker data accepted for presentation at CTAD and full clinical data expected in Q1 2027. This represents a material clinical development milestone for the company's pipeline.

View raw filing on EDGAR →

BIO KEY INTERNATIONAL INC (BKYI)

8-K Auditor Change confidence 95% filed 2026-07-09 Item 4.01

The filing discloses a change in the Company's independent registered public accounting firm: dismissal of Bush & Associates CPA LLC on July 7, 2026, and engagement of M&K CPAS, PLLC on July 2, 2026. This is a classic auditor change under Item 4.01. The materiality is heightened by the fact that Bush & Associates' audit reports included an explanatory paragraph raising substantial doubt about the Company's ability to continue as a going concern, making the auditor transition significant to investors.

View raw filing on EDGAR →

PARK AEROSPACE CORP (PKE)

8-K Exec appointment confidence 85% filed 2026-07-09 Item 5.02

The filing discloses both a departure (Cory Nickel's termination as Senior Vice President and General Manager) and an appointment (John Jamieson's appointment to the same role, effective immediately on July 7, 2026). While both events occurred, the principal disclosed action centers on the appointment of Jamieson to a senior operational role with a salary increase from $193,000 to $205,000. The detailed biographical information and Board approval of compensation changes emphasize the appointment as the primary event. This is material as it involves a change in senior management responsible for operations.

View raw filing on EDGAR →

Travere Therapeutics, Inc. (TVTX)

8-K Exec departure confidence 75% filed 2026-07-09 Item 5.02

Sandra Calvin, the Company's chief accounting officer and principal accounting officer, provided notice on July 6, 2026 of her intention to retire following the filing of the 2027 Form 10-K. While the disclosure also mentions John Torell's expected appointment as her successor, the principal disclosed action is Ms. Calvin's departure. The retirement of a principal accounting officer is material to investors as it affects financial reporting oversight and internal controls.

View raw filing on EDGAR →

Edible Garden AG Inc (EDBLW)

8-K Governance Other confidence 85% filed 2026-07-09 Item 3.03

Edible Garden AG Inc effected a 1-for-45 reverse stock split through a Certificate of Amendment to its Certificate of Incorporation, filed with Delaware on July 8, 2026 and effective July 13, 2026. The reverse stock split materially affects the company's share count and trading mechanics.

View raw filing on EDGAR →

Minerva Gold Inc. (MINR)

8-K Auditor Change confidence 98% filed 2026-07-09 Item 4.01

This is a straightforward auditor change disclosure under Item 4.01. Fruci & Associates II, PLLC was dismissed effective July 7, 2026, and replaced by Boladale Lawal & Co. as the independent registered public accounting firm. The filing explicitly states no disagreements or reportable events occurred, indicating a routine transition rather than one driven by accounting disputes. Auditor changes are material events affecting investor confidence in financial reporting oversight.

View raw filing on EDGAR →

Dreamland Ltd (TDIC)

6-K Dilutive issuance confidence 95% filed 2026-07-09

Dreamland Limited entered into a securities purchase agreement on July 7, 2026, to issue 580,000 Class A ordinary shares and 72,000 Class B ordinary shares to Ms. Seto Wai Yue (a director and CEO) for US$2,445,000 in aggregate gross proceeds. The shares are unregistered and issued in reliance on Regulation S as an offshore transaction to a non-U.S. person. This is a classic private placement of equity securities by a foreign private issuer, materially dilutive to existing shareholders and raising capital through an unregistered issuance.

View raw filing on EDGAR →

Stereotaxis, Inc. (STXS)

8-K M&A activity confidence 98% filed 2026-07-09 Item 7.01

The filing discloses completion of Stereotaxis's acquisition of Robocath for approximately $20 million in cash and Common Stock, as stated in Item 8.01. This is a material acquisition event involving the combination of two robotic surgery companies with complementary technologies and strategic synergies, clearly meeting the definition of M&A activity under Item 1.01/2.01 of the 8-K taxonomy.

View raw filing on EDGAR →

AVAX ONE TECHNOLOGY LTD. (AVX)

8-K Delisting risk confidence 95% filed 2026-07-09

The filing discloses that AVAX One has regained compliance with Nasdaq's minimum bid price requirement ($1.00 per share) after previously falling below it on March 13, 2026. While the immediate delisting threat has been resolved, the company is now subject to a mandatory one-year panel monitor under Nasdaq Listing Rule 5815(d)(4)(B), during which any future non-compliance will result in immediate delisting without cure periods. This is a material disclosure of delisting risk and continued listing status, as it materially affects the registrant's ability to maintain its public listing and investor confidence.

View raw filing on EDGAR →

Eightco Holdings Inc. (ORBS)

8-K Operational Other confidence 72% filed 2026-07-09

The filing discloses an operational update on Eightco's treasury holdings and strategic positioning across three mega-trends (AI, digital identity, creator economy), with specific valuations of holdings in OpenAI ($90M), Beast Industries ($18M), WLD tokens (283M), and ETH (16,278), totaling ~$397M. While the press release emphasizes portfolio composition and market developments affecting those holdings, it does not constitute a formal earnings release, material impairment, M&A activity, or other specifically-defined event type. The disclosure is material to investors assessing the registrant's asset base and strategic direction, but the core event—a treasury/holdings update—fits best within operational_other as a strategic business disclosure that does not match a narrower category.

View raw filing on EDGAR →

GMEX Robotics Corp (GMEX)

6-K Exec appointment confidence 95% filed 2026-07-09 EX-99.1

The exhibit announces the appointment of Brian Hartzband as President of U.S. Operations, a named executive role. The disclosure emphasizes his responsibility for leading U.S. growth strategy, commercial operations, and market expansion—a material operational leadership position. The appointment is presented as a strategic milestone supporting the company's North American expansion and long-term growth execution.

View raw filing on EDGAR →

Newton Golf Company, Inc. (NWTG)

8-K Dilutive issuance confidence 85% filed 2026-07-09

Newton Golf Company exchanged approximately $2.3 million of existing convertible promissory notes for 24,092.61 shares of newly designated Series A Convertible Preferred Stock on July 6, 2026. The Series A Preferred Stock is convertible into Common Stock at $1.00 per share, with forced conversion rights if the stock price reaches $3.00 for 10 consecutive trading days. This represents a dilutive equity issuance that increases the company's share count and potential dilution to existing shareholders, characteristic of a debt-for-equity exchange that raises no new cash but restructures existing obligations into equity form.

View raw filing on EDGAR →

Beyond Air, Inc. (XAIR)

8-K Delisting risk confidence 92% filed 2026-07-09

Beyond Air implemented a 1-for-20 reverse stock split to "raise the per share bid price of the Company's Common Stock above $1.00 per share and bring the Company back into compliance with Nasdaq Listing Rule 5550(a)(2)." This is a direct response to a delisting risk triggered by the stock price falling below the $1.00 minimum bid price requirement. The filing explicitly states the company was out of compliance and needed to regain it, making this a material delisting-risk disclosure.

View raw filing on EDGAR →